查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1591820

高性能医用塑胶市场：按类型、应用分类 - 2025-2030 年全球预测

High Performance Medical Plastics Market by Type (Ethylene Tetrafluoroethylene, Fluoropolymers, High Performance Polyamides), Application (Artificial Cornea, Chemical Tanks, Drug Delivery) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年高性能医用塑胶市场价值为10.5亿美元，预计2024年将达到11.7亿美元，复合年增长率为11.26%，到2030年将达到22.3亿美元。

高性能医用塑胶 (HPMP) 是专为医疗领域高级应用而设计的专用聚合物，具有生物相容性、耐化学性和耐用性等优异性能。这些材料对于医疗设备、植入、手术器材和诊断设备的生产至关重要，可实现更高的精确度、灵活性和安全标准。随着对轻质、可消毒和耐化学腐蚀的医疗设备需求的增加，HPMP 已变得至关重要。应用范围广泛，包括整形外科、心臟病学、药物传输和人工关节。市场成长的主要驱动力是技术进步、老年人口增加、慢性病发病率增加以及对家庭医疗设备的需求不断增长。在微创手术和个人化医疗创新的推动下，生物可吸收和电活性聚合物的商机正在迅速增加。然而，严格的法规环境、不断上涨的材料成本和复杂的製造流程等挑战可能会对成长产生负面影响。原物料价格波动和广泛的研发要求也是主要限制因素。主要的成长机会在于开发具有增强功能和可自订性的新型聚合物和复合材料。投资永续营运并将智慧技术整合到设备中可以提高竞争力。回收医用塑胶的未来进步有可能解决环境影响和成本问题。公司还应该考虑与医疗保健提供者合作，创建价值主导的解决方案。市场的性质反映了技术创新、监管合规性和不断变化的消费者需求之间的动态相互作用，要求公司将技术与对健康标准和消费者趋势的敏锐意识结合起来。透过专注于生物分解性塑胶和智慧材料的前沿研究，公司可以利用未满足的需求和新兴趋势来实现永续的业务成长，同时为改善患者的治疗效果做出贡献。

主要市场统计
基准年[2023] 10.5亿美元
预测年份 [2024] 11.7亿美元
预测年份 [2030] 22.3亿美元
复合年增长率（%） 11.26%

市场动态：快速发展的高性能医用塑胶市场的关键市场洞察

供需的动态交互作用正在改变高性能医用塑胶市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 随着全球可支配收入的增加，对医疗保健解决方案的需求不断增加
    • 对植入先进医疗技术的需求不断增长
    • 精准医疗、人造器官和智慧吸入器的成长潜力
  • 市场限制因素
    • 原物料价格波动
  • 市场机会
    • 对客製化微创设备的偏好日益增长
    • 外科手术中对机器人支援的需求迅速增加
  • 市场挑战
    • 担心手术期间的不良反应

波特五力：驾驭高性能医用塑胶市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对高性能医用塑胶市场的影响

外部宏观环境因素在塑造高性能医用塑胶市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解高性能医用塑胶市场的竞争状况

对高性能医用塑胶市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵高效能医用塑胶市场供应商绩效评估

FPNV 定位矩阵是评估高性能医用塑胶市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，描绘高性能医用塑胶市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，高性能医用塑胶市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地的可支配收入不断增加，增加了对医疗保健解决方案的需求
      • 对植入先进医疗技术的需求不断增长
      • 精准医疗、人造器官和智慧吸入器的成长潜力
    • 抑制因素
      • 原物料价格波动
    • 机会
      • 持续偏好客製化微创设备
      • 外科手术中对机器人辅助的需求正在迅速增加
    • 任务
      • 担心手术副作用
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章高性能医用塑胶市场：按类型

  • 乙烯-四氟乙烯
  • 氟聚合物
  • 高性能聚酰胺
  • 全氟烷氧基
  • 聚酰胺酰亚胺
  • 聚芳醚酮
  • 聚醚酰亚胺
  • 聚醚酮
  • 聚苯硫

第七章 高性能医用塑胶市场：依应用分类

  • 人工角膜
  • 化学品罐
  • 药物输送
  • 医疗设备和工具
  • 药品
  • 义肢/植入
  • 分泌瓶
  • 无菌盒
  • 手术室照明
  • 处理系统

第八章北美、南美洲高性能医用塑胶市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区高性能医用塑胶市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东、非洲高性能医用塑胶市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Arkema SA
  • BASF SE
  • Celanese Corporation
  • Compagnie de Saint-Gobain SA
  • Daikin Industries, Ltd.
  • DOMO Chemicals GmbH
  • Ensinger
  • Grindwell Norton Ltd
  • Kuraray Co., Ltd.
  • Mitsubishi Chemical Corporation
  • Raumedic AG
  • Roechling SE & Co. AG
  • Sekisui Chemical Co., Ltd
  • Trelleborg AB
  • Victrex PLC
Product Code: MRR-46132FF7A173

The High Performance Medical Plastics Market was valued at USD 1.05 billion in 2023, expected to reach USD 1.17 billion in 2024, and is projected to grow at a CAGR of 11.26%, to USD 2.23 billion by 2030.

High Performance Medical Plastics (HPMPs) are specialty polymers designed for advanced applications in the medical field, characterized by their superior properties like biocompatibility, chemical resistance, and durability. These materials are crucial for fabricating medical devices, implants, surgical instruments, and diagnostic equipment, allowing for higher precision, flexibility, and safety standards. As the demand for lightweight, sterilizable, and chemically resistant medical devices increases, HPMPs become essential. The applications span orthopedics, cardiology, drug delivery, and prosthetics, among others. The market growth is primarily driven by technological advancements, an increasing geriatric population, rising incidences of chronic diseases, and the growing demand for home healthcare devices. There's a burgeoning opportunity in bioresorbable and electroactive polymers, spurred by innovations in minimally invasive surgery and personalized medicine. However, challenges such as stringent regulatory environments, high costs of materials, and complex manufacturing processes can affect growth adversely. Raw material price volatility and extensive R&D requirements also pose significant limitations. Key growth opportunities lie in developing novel polymers and composites that offer enhanced functionality and customization. Investments in sustainable practices and integrating smart technology into devices can provide a competitive edge. Moving forward, advancing recycling technologies for medical plastics might address both environmental impacts and cost concerns. Businesses should also consider partnerships with healthcare providers to create value-driven solutions. The market's nature reflects a dynamic interplay of innovation, regulatory compliance, and evolving consumer needs, encouraging companies to blend technology with acute awareness of health standards and consumer trends. By focusing on cutting-edge research into biodegradable plastics and smart materials, companies can capitalize on unmet needs and emerging trends, achieving sustainable business growth while contributing to improved patient outcomes.

KEY MARKET STATISTICS
Base Year [2023] USD 1.05 billion
Estimated Year [2024] USD 1.17 billion
Forecast Year [2030] USD 2.23 billion
CAGR (%) 11.26%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving High Performance Medical Plastics Market

The High Performance Medical Plastics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing need for healthcare solutions with rising disposable income globally
    • Growing demand of advanced medical technology in implants
    • Potential growth attributed to precision medicines, artificial organs and smart inhalers
  • Market Restraints
    • Fluctuation in raw material prices
  • Market Opportunities
    • Ongoing preference for customized minimally invasive devices
    • Surge in need for robotic assistance in surgical operations
  • Market Challenges
    • Concerns over adverse effects upon surgery

Porter's Five Forces: A Strategic Tool for Navigating the High Performance Medical Plastics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the High Performance Medical Plastics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the High Performance Medical Plastics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the High Performance Medical Plastics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the High Performance Medical Plastics Market

A detailed market share analysis in the High Performance Medical Plastics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the High Performance Medical Plastics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the High Performance Medical Plastics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the High Performance Medical Plastics Market

A strategic analysis of the High Performance Medical Plastics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the High Performance Medical Plastics Market, highlighting leading vendors and their innovative profiles. These include Arkema SA, BASF SE, Celanese Corporation, Compagnie de Saint-Gobain S.A., Daikin Industries, Ltd., DOMO Chemicals GmbH, Ensinger, Grindwell Norton Ltd, Kuraray Co., Ltd., Mitsubishi Chemical Corporation, Raumedic AG, Roechling SE & Co. AG, Sekisui Chemical Co., Ltd, Trelleborg AB, and Victrex PLC.

Market Segmentation & Coverage

This research report categorizes the High Performance Medical Plastics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Ethylene Tetrafluoroethylene, Fluoropolymers, High Performance Polyamides, Perfluoroalkoxy, Polyamide-Imide, Polyaryletherketones, Polyetherimide, Polyetherketone, and Polyphenylene Sulfides.
  • Based on Application, market is studied across Artificial Cornea, Chemical Tanks, Drug Delivery, Medical Equipment & Tools, Medical Supplies, Prosthesis & Implants, Secretion Bottles, Sterilizing Boxes, Surgical Theater Luminaries, and Therapeutic System.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing need for healthcare solutions with rising disposable income globally
      • 5.1.1.2. Growing demand of advanced medical technology in implants
      • 5.1.1.3. Potential growth attributed to precision medicines, artificial organs and smart inhalers
    • 5.1.2. Restraints
      • 5.1.2.1. Fluctuation in raw material prices
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing preference for customized minimally invasive devices
      • 5.1.3.2. Surge in need for robotic assistance in surgical operations
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns over adverse effects upon surgery
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. High Performance Medical Plastics Market, by Type

  • 6.1. Introduction
  • 6.2. Ethylene Tetrafluoroethylene
  • 6.3. Fluoropolymers
  • 6.4. High Performance Polyamides
  • 6.5. Perfluoroalkoxy
  • 6.6. Polyamide-Imide
  • 6.7. Polyaryletherketones
  • 6.8. Polyetherimide
  • 6.9. Polyetherketone
  • 6.10. Polyphenylene Sulfides

7. High Performance Medical Plastics Market, by Application

  • 7.1. Introduction
  • 7.2. Artificial Cornea
  • 7.3. Chemical Tanks
  • 7.4. Drug Delivery
  • 7.5. Medical Equipment & Tools
  • 7.6. Medical Supplies
  • 7.7. Prosthesis & Implants
  • 7.8. Secretion Bottles
  • 7.9. Sterilizing Boxes
  • 7.10. Surgical Theater Luminaries
  • 7.11. Therapeutic System

8. Americas High Performance Medical Plastics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific High Performance Medical Plastics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa High Performance Medical Plastics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Arkema SA
  • 2. BASF SE
  • 3. Celanese Corporation
  • 4. Compagnie de Saint-Gobain S.A.
  • 5. Daikin Industries, Ltd.
  • 6. DOMO Chemicals GmbH
  • 7. Ensinger
  • 8. Grindwell Norton Ltd
  • 9. Kuraray Co., Ltd.
  • 10. Mitsubishi Chemical Corporation
  • 11. Raumedic AG
  • 12. Roechling SE & Co. AG
  • 13. Sekisui Chemical Co., Ltd
  • 14. Trelleborg AB
  • 15. Victrex PLC

LIST OF FIGURES

  • FIGURE 1. HIGH PERFORMANCE MEDICAL PLASTICS MARKET RESEARCH PROCESS
  • FIGURE 2. HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. HIGH PERFORMANCE MEDICAL PLASTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. HIGH PERFORMANCE MEDICAL PLASTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HIGH PERFORMANCE MEDICAL PLASTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HIGH PERFORMANCE MEDICAL PLASTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY ETHYLENE TETRAFLUOROETHYLENE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY FLUOROPOLYMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY HIGH PERFORMANCE POLYAMIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY PERFLUOROALKOXY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY POLYAMIDE-IMIDE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY POLYARYLETHERKETONES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY POLYETHERIMIDE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY POLYETHERKETONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY POLYPHENYLENE SULFIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY ARTIFICIAL CORNEA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY CHEMICAL TANKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY MEDICAL EQUIPMENT & TOOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY MEDICAL SUPPLIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY PROSTHESIS & IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY SECRETION BOTTLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY STERILIZING BOXES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY SURGICAL THEATER LUMINARIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY THERAPEUTIC SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. MALAYSIA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. PHILIPPINES HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. PHILIPPINES HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. SINGAPORE HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. SINGAPORE HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. SOUTH KOREA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. SOUTH KOREA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. TAIWAN HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. TAIWAN HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. THAILAND HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. THAILAND HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. VIETNAM HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. VIETNAM HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 72. DENMARK HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. DENMARK HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. EGYPT HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. EGYPT HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. FINLAND HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. FINLAND HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. FRANCE HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. FRANCE HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. GERMANY HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. GERMANY HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. ISRAEL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. ISRAEL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. ITALY HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. ITALY HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. NETHERLANDS HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. NETHERLANDS HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. NIGERIA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. NIGERIA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. NORWAY HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. NORWAY HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. POLAND HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. POLAND HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. QATAR HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. QATAR HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. RUSSIA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. RUSSIA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. SAUDI ARABIA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. SAUDI ARABIA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. SOUTH AFRICA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. SOUTH AFRICA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. SPAIN HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. SPAIN HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. SWEDEN HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. SWEDEN HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. SWITZERLAND HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. SWITZERLAND HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. TURKEY HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. TURKEY HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. UNITED ARAB EMIRATES HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. UNITED ARAB EMIRATES HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. UNITED KINGDOM HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. UNITED KINGDOM HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. HIGH PERFORMANCE MEDICAL PLASTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 115. HIGH PERFORMANCE MEDICAL PLASTICS MARKET, FPNV POSITIONING MATRIX, 2023